• Donesta® Phase III: recruitment completion of American study and additional recruitment in the European study

    Wednesday September 22nd 2021

  • Mithra announces an update on PeriNesta®

    Wednesday September 22nd 2021

  • Galapagos announces positive CHMP opinion for Jyseleca® (filgotinib) for the treatment of adults with moderately to severely active ulcerative colitis

    Friday September 17th 2021

  • Flamingo Therapeutics expands alliance with Ionis Pharmaceuticals to develop RNA-targeted therapies for oncology

    Thursday September 9th 2021

  • Newton Biocapital invests in PRISM BioLab to support development of a unique peptide mimetic technology platform to discover new drugs for intractable diseases

    Thursday September 9th 2021

  • ViroVet and The Pirbright Institute are first to demonstrate efficacy of antivirals in ASFV infected pigs

    Thursday September 9th 2021

  • Publication of Positive Phase 1 Clinical Data evaluating THR-687 for Treatment of DME in Ophthalmology Science

    Tuesday August 17th 2021

  • Belgian MedTech start-up regenerates cartilage

    Thursday June 24th 2021

  • Your news here?

  • Investment in Flow Cytometry unlocks the secrets of single cells

    Thursday May 20th 2021

  • reMYND announces Clinical Advisory Board to support development of Alzheimer’s programme

    Thursday May 20th 2021

  • Eurofins Genomics meets global demand for SARS-CoV-2 full genome sequencing, with over 100,000 sequenced samples in less than 8 weeks

    Thursday May 20th 2021


Strategic Partners